Clinical Trials Directory

Trials / Completed

CompletedNCT02243254

Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postoperative hyperalgesia has been reported after intraoperative administration of small or high-dose remifentanil. Cyclooxygenase inhibitor exhibit preventive effects on the development of opioid-induced hyperalgesia. The aim of this study is to evaluate the preventive effect of intravenous ibuprofen (Caldolor®) on remifentanil-induced hyperalgesia

Conditions

Interventions

TypeNameDescription
DRUGhigh dose remifentanilhigh dose remifentanil
DRUGIbuprofenintravenous ibuprofen
DRUGlow dose remifentanillow dose remifentanil

Timeline

Start date
2014-07-01
Primary completion
2015-04-01
First posted
2014-09-17
Last updated
2015-11-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02243254. Inclusion in this directory is not an endorsement.

Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen (NCT02243254) · Clinical Trials Directory